Ins and Outs

June 18th, 2007 News

Facebook Twitter Google+ LinkedIn

  • Ultra Deep Sequencing Identifies HIV Drug Resistance at Early Stage
    [Yale]
  • New Orphan: FDA approves Letairis (ambrisentan) for the treatment of pulmonary arterial hypertension
    [FDA]
  • F.D.A. Tracked Poisoned Drugs, but Trail Went Cold in China
    [NY Times]
  • Animal Research Uncovers Another Mechanism of Cholesterol Lowering Ezetimibe (Zetia) Drug
    [Wake Forest University School of Medicine]
  • New findings challenge established views about human genome
    [European Molecular Biology Laboratory]
  • Our Microbial Menagerie — New genomic technologies allow us to study the thriving but mysterious populations of microorganisms in our bodies, providing important insights into obesity and other health problems.
    [MIT Tech Review]
  • Gene responsible for common hearing loss identified for first time
    [European Society of Human Genetics]
  • Researchers Discover a Small Set of Cancer Stem Cells That Are Similar To Normal Stem Cells and Appear To Thwart Anti-Cancer Agents
    [University of Pittsburgh School of Medicine ]
  • FDA Releases Human Tissue Task Force Report
    [FDA]
  • Phytomedics, developer of an arthritis drug based on extracts from the Chinese Thunder God Vine, nabs $9 million in Series B funding.
    [Red Herring]
  • To keep fit in space, train like an athlete
    [National Space Biomedical Research Institute]
  • Study: Prehistoric Man Had Sex for Fun
    [Fox News]

    • Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

    © Medgadget, LLC. 2004-2019. All rights reserved. | The Medical Revolution Will Be Blogged.

    MED TECH TRANSFORMS THE WORLD

    Exclusive Medgadget news in your mailbox!

    Your information will never be shared with any third party.

    X